Skip to Main Content

Paper Details

Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States.
PLoS One
0
2023
COVID-19, RNA, SARS, SARS-CoV, SARS-CoV-2, cardiovascular disease, chronic lung, or kidney disease, obesity, patients, people, pneumonia, shortness of breath
Author NameAffiliation
Natalie E Sheils
Shaun J GrannisRegenstrief Institute
Shaun J GrannisDepartment of Informatics and Health Services Research, Indiana University School of Medicine
Rohit VashishtBakar Computational Health Sciences Institute, University of California San Francisco
Rohit VashishtBakar Computational Health Sciences Institute, University of California San Francisco
Peter J EmbiRegenstrief Institute
Peter J EmbiDepartment of Informatics and Health Services Research, Indiana University School of Medicine
Garrett JenkinsonMayo Clinic
Omai B Garneruniversity of california los angeles Medical Center
Lisa DahmCenter for Data-driven Insights and Innovation, University of California Health
Carrie L ByingtonCenter for Data-driven Insights and Innovation, University of California Health
Atul J ButteBakar Computational Health Sciences Institute, University of California San Francisco
Atul J ButteCenter for Data-driven Insights and Innovation, University of California Health
  • 1 - 13

Datasets

Release 1.2